Patent · US Expired

Novel substituted pyrazine, formulations thereof and use in medicine

US5073557A · kind A · utility

2Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 8, 1990
Grant dateDec 17, 1991
Priority date
Expiry dateAug 8, 2010

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The compound (R)-3-[2-(6-chloropyrazin)yl]-1-azabicyclo[2.2.2]octane and its salts behave as M.sub.1, M.sub.3 muscarinic agonists and are useful in the treatment of neurological and mental disorders, preferably in a pharmaceutical formulation comprising the active compound in association with a pharmaceutically acceptable carrier. The compound can be prepared by via methods analogous to those known in the art and a chiral acid resolution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.